TB4 Frag 17–23 is a synthetic peptide fragment derived from Thymosin Beta-4, commonly studied in cellular migration, wound modeling, and tissue response frameworks. This fragment consists of the 17–23 amino acid sequence, a region often evaluated for its functional role in binding to actin and influencing intracellular signaling.
Each capsule contains 500mcg of TB4 Frag 17–23, formulated under cGMP laboratory conditions in the USA and encapsulated for ease of handling in controlled research settings. Supplied in a sealed bottle containing 60 capsules.
This product is not approved for human or veterinary use. For qualified laboratory research only.
Key Specifications
- Peptide Fragment: TB500 17–23 fragment
- Form: Oral capsule
- Per Capsule: 500mcg
- Count: 60 capsules per bottle
- Purity: ≥98% (independently tested)
- Storage: Keep in a cool, dry environment. Do not expose to light or moisture.
Use Restrictions
- This item is strictly for in vitro research use
- Not intended for dietary, therapeutic, or diagnostic applications
- Must be handled by trained professionals
- Keep away from unauthorized access
There are no reviews yet.